Cargando…
Survival Outcomes in Invasive Lobular Carcinoma Compared to Oestrogen Receptor-Positive Invasive Ductal Carcinoma
SIMPLE SUMMARY: Around 10–15% of breast cancer diagnoses are invasive lobular cancers (ILC), and they are currently treated in a similar way to the more common invasive ductal cancer (IDC), although they display different characteristics. The main objective of this study was to identify any differen...
Autores principales: | Timbres, Jasmine, Moss, Charlotte, Mera, Anca, Haire, Anna, Gillett, Cheryl, Van Hemelrijck, Mieke, Sawyer, Elinor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234044/ https://www.ncbi.nlm.nih.gov/pubmed/34207042 http://dx.doi.org/10.3390/cancers13123036 |
Ejemplares similares
-
Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas
por: Delpech, Y, et al.
Publicado: (2013) -
Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer
por: Yates, LR, et al.
Publicado: (2010) -
Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.
por: Lee, A. H., et al.
Publicado: (1996) -
Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma.
por: Toikkanen, S., et al.
Publicado: (1997) -
Classifying invasive lobular carcinoma as special type breast cancer may be reducing its treatment success: A comparison of survival among invasive lobular carcinoma, invasive ductal carcinoma, and no-lobular special type breast cancer
por: Cosar, Rusen, et al.
Publicado: (2023)